IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Resea

POTOMAC, Md.--(BUSINESS WIRE)--#IGC--IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”), a clinical-stage pharmaceutical company, has secured a $12 million revolving line of credit from the Hong Kong Branch of O-Bank Co., Ltd. (“O-Bank” or the “Bank”). This funding will support IGC’s working capital need...

Related Keywords

Hong Kong ,United States ,American ,Ram Mukunda ,Walter Frank ,O Bank Co Ltd ,Pharma Inc ,Bradbury Asset Management Hong Kong ,Bradbury Asset Management Hong Kong Limited ,Hong Kong Branch ,Alzheimer Disease International ,Bradbury Group ,Exchange Commission ,Asset Management ,Disease International ,Loo See Yuen ,Bradbury Asset Management ,Risk Factors ,Annual Report ,